Each PDUFA reauthorization creates a “need to move” legislative motor vehicle on which sector can concentration its Power and lobbying attempts, which Congress need to then consider and vote on inside a confined time-frame, constraining its ability to substantially revise the commitments resulting from FDA-marketplace negotiation.Any spin that